Drug profile

The FDA adverse-event record for Naloxone Hcl

23 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Naloxone Hcl. See the species affected, top reactions, and outcomes below.

23
adverse-event reports
43.5%
death-coded share
Cat
most-reported species
7
Death - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
23
Total Reports
10
Deaths Reported
43.5%
Death Rate

Active Ingredients

Naloxone Hcl

Administration Routes

UnknownIntravenousNasal

Species Affected

Cat 12
Dog 11

Most Affected Breeds

Domestic Shorthair 8
Terrier (unspecified) 3
Pointing Dog - German Short-haired 2
Dog (unknown) 2
Scottish Fold Longhair 1
American Bobtail 1
Siamese 1
Domestic Longhair 1
Boxer (German Boxer) 1
Siberian Husky 1

Most Reported Reactions

Death 7
Cardiac arrest 6
Respiratory arrest 4
Death by euthanasia 3
Tachycardia 3
Other abnormal test result NOS 3
Bradycardia 3
Blindness 3
Pale mucous membrane 3
Hypothermia 3
INEFFECTIVE, REVERSAL 2
Hypotension 2

Outcome Breakdown

Ongoing
7 (30.4%)
Died
7 (30.4%)
Recovered/Normal
6 (26.1%)
Euthanized
3 (13.0%)

Naloxone Hcl Adverse Event Insights

23 reports name Naloxone Hcl; 10 recorded a death outcome (43.5% of reported events, not a population-level mortality rate). Active ingredient: Naloxone Hcl. Administration routes: Unknown, Intravenous, Nasal.

By species: Cat (12 reports), Dog (11 reports). By breed: Domestic Shorthair (8), Terrier (unspecified) (3), Pointing Dog - German Short-haired (2).

Leading clinical signs: Death (7), Cardiac arrest (6), Respiratory arrest (4), Death by euthanasia (3). Outcome, 23 coded reports: Ongoing leads at 30.4%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.